GGrantIndex
← Leaderboards

Rowan T. Chlebowski

La Biomed Res Inst/ Harbor Ucla Med Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$4,676,800
Attributed
$4,676,800
Total exposure
16
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $931.8K · FY2005–07
$1M$750K$500K$250K$0
'05
'06
'07

Funding mix

By agency

NIH$4,676,800 · 16

By mechanism

M01$3,643,154 · 14
N01$591,924 · 1
R01$441,722 · 1

Top collaborators

No co-investigators on record.

Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject”

Research focus

Human SubjectClinical ResearchClinical TrialsBreast NeoplasmsWomen'S HealthNutrition Related TagHuman Therapy EvaluationChemopreventionDietary LipidCancer PreventionFemaleHuman Middle Age (35-64)Outcomes ResearchHormone TherapyDisease /Disorder Prevention /ControlLongitudinal Human StudyColorectal NeoplasmsNeoplasm /Cancer Nutrition TherapyDietary ControlTherapy ComplianceHuman Old Age (65+)Cancer RiskNeoplasm /Cancer Relapse /RecurrencePostmenopause

Grant awards (33)

THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)$206,288
M01 · FY2007 · RR · contact PI
A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS EXEMESTANE PLU$66,243
M01 · FY2007 · RR · contact PI
RESPIRATORY ANCILLARY STUDY (RAS) AS A SUBSTUDY OF SELECT TRIAL$61,564
M01 · FY2007 · RR · contact PI
THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)$393,935
M01 · FY2006 · RR · contact PI
A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS EXEMESTANE PLU$16,207
M01 · FY2006 · RR · contact PI
WEIGHT LOSS IN PUBLIC HOSPITAL BREAST CANCER PATIENTS$5,610
M01 · FY2006 · RR · contact PI
THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)$592,002
M01 · FY2005 · RR
CLINICAL TRIAL&OBSERVATIONAL STUDY OF WOMEN'S HEALTH INIATIVE-WEST$285,598
M01 · FY2005 · RR
WEIGHT LOSS IN PUBLIC HOSPITAL BREAST CANCER PATIENTS$49,176
M01 · FY2005 · RR
LOW FAT DIET &BREAST CANCER RECURRENCE: OUTCOME TRIAL (WINS)$5,044
M01 · FY2005 · RR
Selenium and Vitamin E Chemoprevention Trial (SELECT$721,474
M01 · FY2004 · RR
Clinical Trial&Observational Study of Women's Health Iniative-West$463,438
M01 · FY2004 · RR
LOW FAT DIET AND BREAST CANCER RECURRENCE--OUTCOME TRIAL$441,722
R01 · FY2004 · CA
Low Fat Diet &Breast Cancer Recurrence: Outcome Trial$41,723
M01 · FY2004 · RR
Weight Loss in Public Hospital Breast Cancer Patients$17,972
M01 · FY2004 · RR
CLINICAL TRIAL AND OBSERVATIONAL STUDY OF WOMEN'S HEALTH$237,978
M01 · FY2001 · RR
LOW FAT DIET AND BREAST CANCER RECURRENCE, OUTCOME TRIAL$237,978
M01 · FY2001 · RR
NSABP BREAST CANCER PREVENTION TRIAL$237,978
M01 · FY2001 · RR
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI$1
N01 · FY2001 · WH
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI$591,923
N01 · FY2000 · WH
CLINICAL TRIAL AND OBSERVATIONAL STUDY OF WOMEN'S HEALTH$982
M01 · FY2000 · RR
NSABP BREAST CANCER PREVENTION TRIAL$982
M01 · FY2000 · RR
LOW FAT DIET AND BREAST CANCER RECURRENCE, OUTCOME TRIAL$982
M01 · FY2000 · RR
Acquisition center for the GENNID project$0
M01 · FY2000 · RR
Acquisition center for the GENNID project$0
M01 · FY2000 · RR
LOW FAT DIET AND BREAST CANCER RECURRENCE, OUTCOME TRIAL$0
M01 · FY2000 · RR
CLINICAL TRIAL AND OBSERVATIONAL STUDY OF WOMEN'S HEALTH$0
M01 · FY2000 · RR
CLINICAL TRIAL AND OBSERVATIONAL STUDY OF WOMEN'S HEALTH$0
M01 · FY2000 · RR
NSABP BREAST CANCER PREVENTION TRIAL$0
M01 · FY2000 · RR
NSABP BREAST CANCER PREVENTION TRIAL$0
M01 · FY2000 · RR
LOW FAT DIET AND BREAST CANCER RECURRENCE, OUTCOME TRIAL$0
M01 · FY2000 · RR
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI$0
N01 · FY2000 · WH
Acquisition center for the GENNID project$0
M01 · FY2000 · RR